Arkema SA
OTC:ARKAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arkema SA
OTC:ARKAF
|
FR |
|
C
|
CH Robinson Worldwide Inc
XMUN:CH1A
|
US |
|
R
|
Raphas Co Ltd
KOSDAQ:214260
|
KR |
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
P
|
Penumbra Inc
SWB:0P8
|
US |
|
Paradigm Medical Industries Inc
OTC:PDMI
|
US |
|
L
|
Lakeland Industries Inc
F:LLI
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ARKAF's stock price target?
Price Target
76.33
USD
According to Wall Street analysts, the average 1-year price target for
ARKAF is 76.33 USD with a low forecast of 60.95 USD and a high forecast of 101.38 USD.
What is the Revenue forecast for Arkema SA?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 3%.
What is the Gross Profit forecast for Arkema SA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Arkema SA?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 5 years is 15%.
What is the Pre-Tax Income forecast for Arkema SA?
Projected CAGR
49%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -10%. The projected CAGR for the next 3 years is 49%.
What is the Net Income forecast for Arkema SA?
Projected CAGR
100%
Over the last 13 years, the compound annual growth rate for Net Income has been -12%. The projected CAGR for the next 4 years is 100%.